Barrow Robertinsider trades
In SEC Form 4 filings, Barrow Robert is listed as Chief Executive Officer of Definium Therapeutics, Inc. (DFTX). In the last 90 days, Barrow Robert sold $1.88M of Definium Therapeutics, Inc. (DFTX) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| DFTXDefinium Therapeutics, Inc. | Chief Executive Officer | 4 | Sep 29 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-04
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| DFTXDefinium Therapeutics, Inc. | Sep 25 | Sep 29 | S | 31,550 | $36.57 | Sale −$1,153,784 | 2,213,090 | Yes | Form 4 |
| DFTXDefinium Therapeutics, Inc. | Sep 14 | Sep 14 | A | 750,000 | $0.00 | $0 | 2,244,640 | No | Form 4 |
| DFTXDefinium Therapeutics, Inc. | Sep 3 | Sep 4 | S | 19,023 | $37.94 | Sale −$721,733 | 1,494,640 | Yes | Form 4 |
| DFTXDefinium Therapeutics, Inc. | Sep 2 | Sep 4 | A | 40,000 | $0.00 | $0 | 1,513,663 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.